CRSP 最新季度财报
公布日期11/2/2026
实际每股收益(美元)-1.15
实际营收(美元)12.67M
本页面提供详细的 CRISPR Therapeutics AG 财报数据,包括最新财报、下一次财报发布日期、历史数据及 CRISPR Therapeutics AG 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 11/2/2026 | 09/2026 | -1.15/-1.04 | 12.67M/10.49M | -11.01% | 20.72% |
| 8/3/2026 | 06/2026 | -0.94/-1.20 | 10.18M/6.79M | 21.13% | 49.96% |
| 5/4/2026 | 03/2026 | -1.28/-1.22 | 1.46M/2.70M | -4.53% | -46.00% |
| 2/12/2026 | 12/2025 | -1.37/-1.15 | 864.00K/4.24M | -18.77% | -79.63% |
| 11/10/2025 | 09/2025 | -1.17/-1.26 | 889.00K/8.90M | 7.56% | -90.02% |
| 8/4/2025 | 06/2025 | -2.40/-1.42 | 892.00K/6.25M | -68.11% | -85.74% |
| 5/6/2025 | 03/2025 | -1.58/-1.25 | 865.00K/6.50M | -26.54% | -86.69% |
| 2/11/2025 | 12/2024 | -0.44/-1.17 | 35.69M/7.89M | 62.64% | 352.59% |